China Resources Double-Crane Plans to Acquire About 23.5% Stake in Lier Chemical

Corporate Action
โดย 财中社·Read original
Summary · why it matters

China Resources Double-Crane, an indirect non-wholly-owned subsidiary of China Resources Pharmaceutical, has participated in the acquisition of 188 million shares of Lier Chemical, representing approximately 23.50% of Lier Chemical's equity. China Resources Double-Crane received notice from the seller confirming that it is the top-ranked intended transferee in the above-mentioned public solicitation transfer. Lier Chemical is mainly engaged in the research, development, production and sales of high-efficiency, low-toxicity, low-residue and safe pesticide active ingredients and pesticide formulations.

Impact on stocks 4

Biotech & Genomic Medicine▲ · 1 stocks
Others▲ · 3 stocks
Lier Chemical Co Ltd
002258
▲ PositiveCapitalrelevance

Lier Chemical is the target of a stake acquisition by China Resources Double-Crane, likely positive for valuation.

© 2026 MarketDXNews